RADIOPHARM THERANOSTICS LIMITED

Press Releases Radiopharm Theranostics Limited

Equities

RAD

AU0000181851

Delayed Australian S.E. Other stock markets 01:06:50 2024-05-24 am EDT			5-day change	1st Jan Change
0.033 ^AUD	0.00%		-8.33%	-55.41%

May. 08	Radiopharm Theranostics to be Featured in Healthcare Events Hosted by B. Riley Securities	MT
Feb. 29	Radiopharm Theranostics Doses First Patient in Pancreatic Cancer Imaging Study	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

RAD receives approval for Phase 1 therapeutic study of PDL1-nanobody in Non-Small Cell Lung Cancer	23-10-09	AQ
Radiopharm Theranostics Expands Supply Agreement With TerThera for Terbium-161 Isotope Use in Prostate Cancer	23-08-24	AQ
Radiopharm welcomes positive guidance from FDA to advance Pivalate	23-05-31	AQ
Radiopharm Theranostics Receives FDA Orphan Drug Designation for Trivehexin (RAD 301) in Pancreatic Cancer	23-05-09	AQ
Radiopharm Theranostics secures pivotal isotope for cancer-targeting peptide	23-04-18	AQ
Radiopharm Theranostics Enters Into Supply Agreement with TerThera for Terbium-161 Isotope	23-04-17	AQ
Radiopharm Theranostics Invited to Participate in Jefferies Radiopharma Innovation Summit	23-03-28	AQ
Radiopharm Theranostics Partners With Next Generation Preclinical Platform for Therapeutic Radiopharmaceuticals	23-03-03	AQ
Dr Ken Herrmann Appointed to RAD Scientific Advisory Board	23-03-03	AQ
Radiopharm Theranostics talks clinical development and Nasdaq listing	23-02-14	AQ
Radiopharm Theranostics Initiates Process for Nasdaq Listing	23-02-14	AQ
Radiopharm Theranostics Signs Agreement With NorthStar Medical Radioisotopes for the Supply of Non-Carrier Added (n.c.a.) Actinium-225	22-10-26	BU
Radiopharm Theranostics : RAD Dual Action Antibody Investor Deck	22-04-03	PU
Australian IPO Review 2021: Pre–IPO Capital Raises	22-02-28	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

The best tools reserved for subscribers to boost the performance of your investments!

Optimize my profits

fermer